Determination of body mass index and physical activity in normal weight children and evaluation of salivary levels of interleukin 10 and interleukin 17

Clinical Immunology, Endocrine and Metabolic Drugs

Volumn 1, Issue 2, 2014, Pages 81-88

  Vitale, Elsa ^a   Jirillo, Emilio ^a   Magrone, Thea ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Body mass index; High fat meal; Interleukin 10; Interleukin 17; Low grade inflammation; Physical activity; Saliva

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 17;

ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHILD; CYTOKINE PRODUCTION; DIETARY INTAKE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH STATUS; HUMAN; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SCHOOL CHILD; SPORT;

EID: 84978335468     PISSN: 22127070     EISSN: 22127089     Source Type: Journal    
DOI: 10.2174/2212707002666150402225920     Document Type: Article

References (42)

1. European Food Safety Authority. Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies on a request from the EC on Food-Based Dietary Guidelines. Question No EFSQ-Q-2005-015c. Agreed on 2 July 2008 for release for public consultation. http://www.efsa.europa.eu/en/efsajournal/pub/1460.htm
2. Spindler-Vesel A, Wraber B, Vovk I, Kompan, L. Intestinal permeability and cytokine inflammatory response in multiply injured patients. J Interferon Cytokine Res 2006; 26: 771-6.
3. Manco M, Putignani L, Bottazzo GF. Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev 2010; 31: 817-44.
4. Valdés-Ramos R, Martínez-Carrillo BE, Aranda-González II, et al. Diet, exercise and gut mucosal immunity. Proc Nutr Soc 2010; 69: 644-50.
5. Aschbacher K, Kornfeld S, Picard M, et al. Chronic stress increases vulnerability to diet-related abdominal fat, oxidative stress, and metabolic risk. Psychoneuroendocrinology 2014; 46: 14-22.
6. Poljsak B. Strategies for reducing or preventing the generation of oxidative stress. Oxid Med Cell Longev 2011; 2011: 194586.
7. Alipour A, Elte JWF, van Zaanen HCT, Rietveld AP, Cabezas MC. Postprandial inflammation and endothelial dysfunction. Biochem Soc Trans 2007; 35: 464-9.
8. Klop B, Proctor SD, Mamo JC, Botham KM, Castro Cabezas M. Understanding postprandial inflammation and its relationship to lifestyle behaviour and metabolic diseases. Int J Vasc Med 2012; 2012: 947417.
9. O’Keefe JH, Bell DS. Postprandial hyperglycemia/ hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am J Cardiol 2007; 100: 899-904.
10. Wärnberg J, Cunningham K, Romeo J, Marcos A. Physical activity, exercise and low-grade systemic inflammation. Proc Nutr Soc 2010; 69: 400-6.
11. Alvarez JA, Higgins PB, Oster RA, Fernandez JR, Darnell BE, Gower BA. Fasting and postprandial markers of inflammation in lean and overweight children. Am J Clin Nutr 2009; 89: 1138-44.
12. Krogh-Madsen R, Pedersen M, Solomon TP, et al. Normal physical activity obliterates the deleterious effects of a high-caloric intake. J Appl Physiol 2013; 116: 231-9.
13. Lancaster GI, Febbraio MA. The immunomodulating role of exercise in metabolic disease. Trends Immunol 2014; 35: 262-9.
14. Abeysekara P, Turchi R, O’Neil M. Obesity and children with special healthcare needs: special considerations for a special population. Curr Opin Pediatr 2014; 26: 508-15.
15. Del Chirico F, Vernocchi P, Dallapiccola B, Putignani L. Mediterranean diet and health: food effects on gut microbiota and disease control. Int J Mol Sci 2014; 15: 11678-99.
16. Cao AT, Yao S, Stefka AT, et al. TLR4 regulates IFN-γ and IL-17 production by both thymic and induced Foxp3+ Tregs during intestinal inflammation. J Leukoc Biol 2014; 96: 895-905.
17. Weber A, Zimmermann C, Kieseier BC, Hartung HP, Hofstetter HH. Bacteria and their cell wall components uniformly co-active IL-17 producing thymocytes. Clin Exp Immunol 2014; 178: 504-15.
18. Cosmi L, Liotta F, Maggi E, Romagnani S, Annunziato F. Th17 and non-classic Th1 cells in chronic inflammatory disorders: two sides of the same coin. Int Arch Allergy Immunol 2014; 164: 171-7.
19. Hu Z, Hongbo C. The interplay between regulatory T cells and metabolism in immune regulation. Onco-Immunology 2013; 2: 1-7.
20. QIyer SS, Cheng G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol 2012; 32: 23-63.
21. Pereira S, Teixeira L, Aguilar E, et al. Modulation of adipose tissue inflammation by FOXP3+ Treg cell, IL-10, and TGF-β in metabolically healthy class III obese individuals. Nutrition 2014; 30: 784-90.
22. Cole TJ Lobstein T. Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity. Pediatr Obes 2012; 7: 284-94.
23. European Food Safety Authority. Development of Food-based Dietary Guidelines. EFSA Scientific Colloquium. 2007; Parma, Italy: EFSA.
24. Kreuser F, Kromeyer-Hauschild K, Gollhofer A, Korsten-Reck U, Rottger K. Obese equals lazy? Analysis of the association between weight status and physical activity in children. J Obes 2013; 2013: 1-8.
25. Branca F. The WHO diet and physical activity strategy and the nutrition agenda in the European region. Presented at Unilever Satellite Workshop: Food products and dietary guidelines: How to align? Sixth International Conference on Dietary Assessment Methods (ICDAM), 2006; Copenhagen.
26. Lin CY, Su CT, Ma HI. Objectively measured physical activity patterns and quality of life of overweight boys: a preliminary study. Hong Kong J Occup Ther 2012; 22: 31-7.
27. Vitale E, Jirillo E, Magrone T. Correlations between the Youth Healthy Eating Index, Body Mass Index and the Salivary Nitric Oxide Concentration in Overweight/ Obese Children. Endocr Metab Immune Disord Drug Targets 2014; 14: 93-101.
28. Lloyd-Jones DM, Hong Y, Labarthe D. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic impact goal through 2020 and beyond. Circulation 2010; 121: 586-613.
29. O’Keefe JH, Gheewala NM, O’Keefe JO. Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health. J Am Coll Cardiol 2008; 51: 249-55.
30. Holt EM, Steffen LM, Moran A. et al. Fruit and vegetable consumption and its relation to markers of inflammation and oxidative stress in adolescents. J Am Diet Assoc 2009; 109: 414-21.
31. Casas R, Sacanella E, Urpì-Sardà M. The effects of the Mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial. PLoS One 2014; 9: e100084.
32. Bonaccio M, Di Castelnuovo A, Bonanni A. et al. Decline of the Mediterranean diet at a time of economic crisis. Results from the Moli-sani study. Nutr Metab Cardiovasc Dis 2014; 24: 853-60.
33. Lim GB. Risk factors: mechanistic insights into the cardiovascular benefits of a Mediterranean diet. Nat Rev Cardiol 2014; 11: 433.
34. Knoops KT, de Groot LC, Kromhout D, et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA 2004; 292: 1433-9.
35. Vierira VJ, Rudy JV, Kenneth RW, Nirav A, Tracy B, Jeffrey AW. Effects of exercise and low-fat diet on adipose tissue inflammation and metabolic complications in obese mice. Am J Phtsiol Endocrinol Metab 2009; 296: E1164-E71.
36. Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, Nimmo MA. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol 2011; 11: 607-11.
37. Miglio C, Peluso I, Raguzzini A, et al. Antioxidant and antiinflammatory response following high-fat meal consumption in overweight subjects. Eur J Nutr 2012; 52: 1107-14.
38. Cuenca-Garcìa M, Ortega FB, Ruiz JR, et al. More physically active and leaner adolescents have higher energy intake. J Pediatr 2014; 164: 159-66.
39. Calder PC, Ahluwalia N, Brouns F, et al. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr 2011; 106: S5-78.
40. Korhonen R, Kosonen O, Hamalainen M, Moilanen E. Nitric oxide-releasing compounds inhibit the production of interleukin-2, -4 and -10 in activated human lymphocytes. Basic Clin Pharmacol Toxicol 2008; 103: 322-8.
41. Feuerer M, Herrero L, Cipolletta D, et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 2009; 15: 930-9.
42. Cani PD, Bibiloni R, Knauf C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008; 57: 1470-81.